Centre Testing International Group Co. Ltd. Share Price
Stocks
300012
CNE100000GV8
Business Support Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.60 CNY | +1.27% |
|
-2.44% | +0.37% |
| 04-27 | Bioduro and Cti Biotechnology Form Strategic Partnership for Preclinical Drug Development | CI |
| 04-21 | Declaration of Voting Results by Centre Testing International | CI |
| Market Cap | 22.75B 3.36B 2.95B 2.74B 2.52B 4.73B 325B 4.82B 32.81B 12.8B 159B 12.61B 12.34B 550B | P/E 2026 * |
19.3x | P/E 2027 * | 16.7x |
|---|---|---|---|---|---|
| Enterprise Value | 20.95B 3.09B 2.72B 2.53B 2.32B 4.36B 300B 4.44B 30.22B 11.79B 146B 11.61B 11.36B 507B | EV / Sales 2026 * |
2.77x | EV / Sales 2027 * | 2.42x |
| Free-Float |
79.89% | Yield 2026 * |
1.35% | Yield 2027 * | 1.59% |
| 1 day | +1.27% | ||
| 1 week | -2.44% | ||
| Current month | -1.88% | ||
| 1 month | -4.96% | ||
| 3 months | -20.70% | ||
| 6 months | -17.97% | ||
| Current year | +0.37% |
| 1 week | 13 |  | 13.76 |
| 1 month | 12.85 | | 15.3 |
| Current year | 12.85 | | 17.97 |
| 1 year | 12.1 | | 17.97 |
| 3 years | 9.48 | | 21.1 |
| 5 years | 9.48 | | 29.86 |
| 10 years | 3.36 | | 35.3 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/12/22 | Sell | Director | 380,000 | 0.0250% | ||
| 29/12/22 | Sell | 230,000 | 0.0151% | |||
| 29/12/22 | Sell | 100,000 | 0.0066% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.27% | -2.44% | +11.84% | -31.86% | 3.36B | |
| -2.20% | -1.57% | +12.19% | +13.25% | 23.22B | |
| +0.60% | -3.45% | +23.15% | - | 17.46B | |
| +0.28% | -10.58% | +23.88% | -1.24% | 2.5B | |
| +5.71% | +9.32% | -27.88% | -36.16% | 2.08B | |
| -2.79% | +0.72% | -40.98% | - | 1.55B | |
| -4.74% | -27.94% | +78.00% | +109.76% | 1.5B | |
| +0.62% | -5.73% | -5.78% | +0.99% | 1.48B | |
| +2.20% | +0.55% | -14.76% | -3.49% | 1.3B | |
| -2.97% | -25.33% | +55.07% | +126.24% | 1.09B | |
| Average | -0.21% | -0.93% | +11.47% | +22.19% | 5.55B | |
| Weighted average by Cap. | -0.65% | +0.10% | +14.66% | +11.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.57B 1.12B 983M 913M 840M 1.58B 108B 1.6B 10.92B 4.26B 52.79B 4.2B 4.11B 183B | 8.52B 1.26B 1.11B 1.03B 945M 1.77B 122B 1.8B 12.29B 4.79B 59.42B 4.72B 4.62B 206B |
| Net income | 1.19B 175M 154M 143M 132M 247M 16.99B 252M 1.71B 669M 8.29B 659M 644M 28.75B | 1.37B 203M 178M 166M 152M 286M 19.62B 291M 1.98B 772M 9.57B 761M 744M 33.21B |
| Net Debt | -1.8B -266M -234M -217M -200M -375M -25.75B -381M -2.6B -1.01B -12.56B -998M -977M -43.57B | -2.12B -313M -275M -256M -235M -441M -30.3B -449M -3.06B -1.19B -14.78B -1.17B -1.15B -51.27B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/07/26 | CN¥13.60 | +1.27% | 18,405,829 |
| 22/07/26 | CN¥13.43 | -1.54% | 25,205,426 |
| 21/07/26 | CN¥13.64 | +0.96% | 32,722,351 |
| 20/07/26 | CN¥13.51 | +1.89% | 40,172,643 |
| 17/07/26 | CN¥13.26 | -4.88% | 53,970,636 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 300012 Stock
Select your edition
All financial news and data tailored to specific country editions
